Bharat Biotech, Biological E together hold about 250 million COVID vaccine doses Ruchika Sharma28 Dec 2022 2:43 PM ISTBharat Biotech sources said the vaccine maker has more than 50 million doses of Covaxin readily available in vials, and over 200 million doses as drug...
COVID intranasal vaccine: Bharat Biotech iNCOVACC priced at Rs 800 for private hospitals, Rs 325 for Govt Ruchika Sharma27 Dec 2022 2:30 PM ISTiNCOVACC is the world's first intranasal vaccine for COVID to receive approval for the primary two-dose schedule, and as a heterologous booster dose.
BioNTech, Fosun Pharma get full regulatory approval for COMIRNATY in individuals 12 years and older in Hong Kong Ruchika Sharma27 Dec 2022 1:30 PM ISTShanghai: BioNTech SE and Shanghai Fosun Pharmaceutical (Group) Co., Ltd. have announced that the Fosun Industrial Co., Limited (as a...
Bharat Biotech intranasal COVID vaccine approved by Centre, to be available on CO-WIN Roshni Dhar24 Dec 2022 4:42 PM ISTThe central government has approved the use of Bharat Biotech's nasal Covid vaccine iNCOVACC to be included in the country's vaccination programme as...
Health Bulletin 24/ December/ 2022 Roshni Dhar24 Dec 2022 4:32 PM ISTHere are the top health stories for the day:Fully prepared to deal with any eventuality, say Delhi hospitals amid coronavirus scareAmid concerns over...
Moderna fires back at Pfizer counterclaims in COVID vaccine patent lawsuit Ruchika Sharma24 Dec 2022 12:30 PM ISTModerna asked for an undisclosed amount of money damages from Pfizer COVID-19 vaccines sold since March.
Centre nod to Bharat Biotech nasal COVID vaccine iNCOVACC, to be availabile in private hospitals Ruchika Sharma23 Dec 2022 3:31 PM ISTiNCOVACC is a recombinant replication-deficient adenovirus vectored vaccine with a pre-fusion stabilized SARS-CoV-2 spike protein.
Pfizer eyes USD 10 billion- USD 15 billion in potential revenue from mRNA vaccines by 2030 Ruchika Sharma13 Dec 2022 12:13 PM ISTNew York: Pfizer Inc said on Monday that annual revenue from its mRNA vaccine portfolio could reach $10 billion to $15 billion by 2030, alleviating...
Include intranasal COVID vaccine iNCOVACC in CoWIN portal: Bharat Biotech urges Centre Ruchika Sharma12 Dec 2022 12:30 PM ISTCurrently, Bharat Biotech's Covaxin, Serum Institute's Covishield and Covovax, Russian Sputink V, and Biological E Ltd's Corbevax are listed in the...
Novavax Nuvaxovid COVID vaccine approved in Canada for use as primary series in adolescents Ruchika Sharma8 Dec 2022 10:15 AM ISTGaithersburg: Novavax, Inc. has announced that Health Canada has approved a supplement to a New Drug Submission (sNDS) for Nuvaxovid (COVID-19 Vaccine...
Britain health regulator authorizes Pfizer-BioNTech COVID vaccine for children aged 6 months to 4 years old Ruchika Sharma7 Dec 2022 4:30 PM ISTThe vaccine is tailored for use in this age group - it is a lower dose version than the one used in children aged five to 11 years.
Pfizer, BioNTech countersue Moderna over COVID-19 vaccine patents Ruchika Sharma6 Dec 2022 1:30 PM ISTPfizer and BioNTech said in their Monday filing that they developed their vaccine independently, calling Moderna's lawsuit "revisionist history" and...
